Purdue Asks Fed. Circ. To Revive Anti-Abuse OxyContin IP
Purdue Pharma urged a Federal Circuit panel Tuesday to resurrect claims of a patent for an abuse-resistant variety of the pain medication OxyContin asserted against generic maker Amneal Pharmaceuticals LLC, saying...To view the full article, register now.
Already a subscriber? Click here to view full article